Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3421239 | 1.00 | ALDH1A1 (0.38) | ALDH1A1CYP3A4ALOX15TDP1GSTP1 | |
| SCHEMBL3639614 | 0.94 | ALDH1A1 (0.39) | ALDH1A1CYP3A4ALOX15TDP1GSTP1 | |
| SCHEMBL3639610 | 0.94 | ALDH1A1 (0.39) | ALDH1A1CYP3A4ALOX15TDP1GSTP1 | |
| SCHEMBL3643551 | 0.86 | ALDH1A1 (0.37) | ALDH1A1CYP3A4ALOX15TDP1 | |
| SCHEMBL3643554 | 0.86 | ALDH1A1 (0.37) | ALDH1A1CYP3A4ALOX15TDP1 | |
| SCHEMBL3643321 | 0.86 | GSTP1 (0.31) | ALDH1A1CYP3A4ALOX15TDP1GSTP1 | |
| SCHEMBL3643324 | 0.86 | GSTP1 (0.31) | ALDH1A1CYP3A4ALOX15TDP1GSTP1 | |
| SCHEMBL18529411 | 0.81 | ALDH1A1 (0.49) | ALDH1A1CYP3A4ALOX15TDP1GSTP1 | |
| SCHEMBL11449382 | 0.81 | ALDH1A1 (0.49) | ALDH1A1CYP3A4ALOX15TDP1GSTP1 | |
| SCHEMBL18529410 | 0.81 | ALDH1A1 (0.49) | ALDH1A1CYP3A4ALOX15TDP1GSTP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2167621-B1 | ORGANIC COMPOUNDS AS ODORANTS | GIVAUDAN SA (CH) | 2017-10-11 | — | — | EP | claimed |
| US-9012391-B2 | Organic compounds | GIVAUDAN SA (CH) | 2015-04-21 | — | — | US | claimed |
| US-20100292128-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2010-11-18 | — | — | US | claimed |
| EP-2167621-A1 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2010-03-31 | — | — | EP | claimed |
| WO-2008151455-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2008-12-18 | — | — | WO | claimed |
| EP-2167621-B1 | ORGANIC COMPOUNDS AS ODORANTS | GIVAUDAN SA (CH) | 2017-10-11 | — | — | EP | disclosed |
| US-9012391-B2 | Organic compounds | GIVAUDAN SA (CH) | 2015-04-21 | — | — | US | disclosed |
| EP-2167463-B1 | CYSTEINE DERIVATIVES WHICH COUNTERACT MALODOUR | GIVAUDAN SA (CH) | 2013-06-12 | — | — | EP | disclosed |
| US-7846887-B2 | Cysteine derivatives which counteract malodour | GIVAUDAN SA (CH) | 2010-12-07 | — | — | US | disclosed |
| US-20100292128-A1 | Organic Compounds | GIVAUDAN SA (CH) | 2010-11-18 | — | — | US | disclosed |
| US-20100179088-A1 | Cysteine Derivatives Which Counteract Malodour | GIVAUDAN SA (CH) | 2010-07-15 | — | — | US | disclosed |
| EP-2167621-A1 | ORGANIC COMPOUNDS | Givaudan SA (CH) | 2010-03-31 | — | — | EP | disclosed |
| EP-2167463-A1 | CYSTEINE DERIVATIVES WHICH COUNTERACT MALODOUR | Givaudan SA (CH) | 2010-03-31 | — | — | EP | disclosed |
| WO-2008154765-A1 | CYSTEINE DERIVATIVES WHICH COUNTERACT MALODOUR | GIVAUDAN SA (CH) | 2008-12-24 | — | — | WO | disclosed |
| WO-2008151455-A1 | ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2008-12-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100179088-A1 | Cysteine Derivatives Which Counteract Malodour | CBR3, CBR1, GSR | ALDH1A1 199/4885CYP3A4 535/4885ALOX15 1498/4885 |
| US-20100292128-A1 | Organic Compounds | TRPA1, FASN, OR10J3 | ALDH1A1 99/4885CYP3A4 105/4885ALOX15 190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.